Form 4: Repligen Senior VP Sells Shares for Tax Obligations

Repligen's Senior VP of R&D, Ralf Kuriyel, reported the disposition of shares to cover tax liabilities arising from restricted stock unit vesting.

Summary

• Ralf Kuriyel, Senior VP of Research & Development at Repligen Corporation, reported two transactions involving the disposition of common stock.
• On February 27, 2026, 444 shares of common stock were disposed of at a price of $128.73 per share.
• On March 2, 2026, an additional 923 shares of common stock were disposed of at a price of $124.97 per share.
• These dispositions were not open market sales but represented shares withheld by Repligen to satisfy tax withholding obligations related to the vesting of restricted stock units.
• Following these transactions, Ralf Kuriyel beneficially owns 14,695 shares of Repligen common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. It is a routine administrative transaction related to executive compensation and does not indicate a change in the company's operational or financial health.

Positives

• The transactions indicate the vesting of restricted stock units, suggesting that the executive is receiving equity compensation as part of their compensation package, which aligns executive incentives with shareholder value over time.

Negatives

• The disposition of shares, even for tax purposes, reduces the executive's direct ownership stake in the company, albeit by a relatively small percentage in this instance.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

StockSavvy.ai notes that tax-related dispositions of shares are a routine occurrence for executives in publicly traded companies, particularly in the biotechnology sector where equity compensation, such as restricted stock units, is a common component of executive pay. These transactions typically do not reflect a change in management's outlook on the company's prospects.

Stakeholder Impact

• Shareholders: The reduction in direct ownership by a Senior VP is minimal and is a standard part of equity compensation, unlikely to significantly impact shareholder sentiment or company strategy.
• Employees: The vesting of RSUs and subsequent tax withholding is a common practice in executive compensation, reflecting standard benefits for senior leadership.

Key Dates

Recommendation

This Form 4 filing details a routine tax-related disposition of shares by a Senior VP following RSU vesting. It does not provide new information regarding the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate as this event is neutral to the company's fundamentals.

Keywords

Repligen, RGEN, Form 4, Insider Transaction, Tax Withholding, Restricted Stock Units, Executive Compensation, Biotechnology